Mindfulness Interventions and Chronic Widespread Pain in Adolescents
CompletedNot applicableNCT02190474
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary objective of this study to determine the feasibility and acceptability of a mindfulness intervention for adolescents with juvenile fibromyalgia/ chronic widespread pain and other similar chronic symptoms.
Study details
- Official title
- Mindfulness Interventions and Chronic Symptoms
- Conditions
- Interventions
- Behavioral: Mindfulness Group
- Sponsor
- Yale University
- Collaborators
- National Institutes of Health (NIH); National Center for Complementary and Integrative Health (NCCIH)
- Start date
- 2014-07
- Primary completion
- 2016-12
- Sex
- All
- Age range
- from 12 Years to 17 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 2010 American College of Rheumatology (ACR) criteria based on the Widespread Pain Index (WPI) and Symptom Severity (SS) checklist. * Functional Disability Score ≥13 indicating at least moderate disability * Average pain intensity in the past week ≥ 4 on a 0-10 cm Visual Analog Scale. * Access to mobile telephone/smartphone with text messaging plan in order to receive survey questions. * Chronic symptoms such as fatigue, pain, bowel dysfunction, perceived cognitive impairment, or other non-specific symptoms persisting for 3-months or more, severe enough to have led to more than one visit to a medical provider. These symptoms must have not been found to be due to a definable general medical disorder despite adequate evaluation. Exclusion Criteria: * Diagnosis of an autoimmune or rheumatologic disease * Current regular mindfulness meditation activity * Serious illness (including mental illness/psychopathology) within 90 days prior to screening * Inability or unwillingness of a parent to give consent/permission or child to assent * Current use of opioid analgesics * Current prescription for antidepressant medications * Screening positive on the Columbia Suicide Screen (CSS) * Active participation (weekly or more often) in a fibromyalgia or chronic disease support group
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02190474